Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2013-02-26 19:03:42 UTC |
---|
Update Date | 2021-09-14 15:45:14 UTC |
---|
HMDB ID | HMDB0059777 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate |
---|
Description | 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate, also known as kodaflex txib, belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate is an extremely weak basic (essentially neutral) compound (based on its pKa). 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate is a potentially toxic compound. These are organic compounds containing an acyclic 2,2,4-trimethylpentane moiety. |
---|
Structure | CC(C)C(OC(=O)C(C)C)C(C)(C)COC(=O)C(C)C InChI=1S/C16H30O4/c1-10(2)13(20-15(18)12(5)6)16(7,8)9-19-14(17)11(3)4/h10-13H,9H2,1-8H3 |
---|
Synonyms | Value | Source |
---|
2,2,4-Trimethyl-1,3-pentadienol diisobutyric acid | Generator | Kodaflex txib | HMDB | 2,2,4-Trimethyl-1,3-pentanediol diisobutyrate | HMDB | 2,2,4-Trimethyl-1-[(2-methylpropanoyl)oxy]pentan-3-yl 2-methylpropanoic acid | Generator |
|
---|
Chemical Formula | C16H30O4 |
---|
Average Molecular Weight | 286.407 |
---|
Monoisotopic Molecular Weight | 286.214409448 |
---|
IUPAC Name | 2,2,4-trimethyl-1-[(2-methylpropanoyl)oxy]pentan-3-yl 2-methylpropanoate |
---|
Traditional Name | 2,2,4-trimethyl-1-[(2-methylpropanoyl)oxy]pentan-3-yl 2-methylpropanoate |
---|
CAS Registry Number | Not Available |
---|
SMILES | CC(C)C(OC(=O)C(C)C)C(C)(C)COC(=O)C(C)C |
---|
InChI Identifier | InChI=1S/C16H30O4/c1-10(2)13(20-15(18)12(5)6)16(7,8)9-19-14(17)11(3)4/h10-13H,9H2,1-8H3 |
---|
InChI Key | OMVSWZDEEGIJJI-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Dicarboxylic acids and derivatives |
---|
Direct Parent | Dicarboxylic acids and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Dicarboxylic acid or derivatives
- Carboxylic acid ester
- Organic oxygen compound
- Organic oxide
- Hydrocarbon derivative
- Organooxygen compound
- Carbonyl group
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatized |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate GC-MS (Non-derivatized) - 70eV, Positive | splash10-006x-9320000000-45edf1349978e3e851e3 | 2017-09-20 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate Orbitrap 12V, positive-QTOF | splash10-0a4i-0009000000-dd955c12c283c9d496a3 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate Orbitrap 13V, positive-QTOF | splash10-0a4i-0209000000-cc825cb93e30e80ed689 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate Orbitrap 15V, positive-QTOF | splash10-0bt9-3609000000-f3741c9036886ba96f4d | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate Orbitrap 17V, positive-QTOF | splash10-02t9-9703000000-c2e7e53100a859988508 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate Orbitrap 21V, positive-QTOF | splash10-014i-9100000000-aa588e35931c2777bfa8 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate Orbitrap 26V, positive-QTOF | splash10-014i-9000000000-c506707519903fd11c05 | 2020-07-22 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate n/a 20V, positive-QTOF | splash10-00di-0190000000-2c58c8574692967bff49 | 2020-07-22 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 10V, Positive-QTOF | splash10-000b-3970000000-50044bbe0f1809f8f660 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 20V, Positive-QTOF | splash10-006t-7910000000-0b27b73ceaa44735ba18 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 40V, Positive-QTOF | splash10-00dl-9200000000-0dd681ac8eaafe9efc13 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 10V, Negative-QTOF | splash10-000i-2290000000-656e107d310f0608ffb9 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 20V, Negative-QTOF | splash10-000i-9540000000-2c499101a60e88230bb4 | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 40V, Negative-QTOF | splash10-00kr-9400000000-7a2db006e7bb84b8411f | 2016-08-04 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 10V, Positive-QTOF | splash10-01p2-1940000000-7e183af9d9a542495b22 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 20V, Positive-QTOF | splash10-0kmi-8900000000-77b6cb754bd14e31bff4 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 40V, Positive-QTOF | splash10-00di-9300000000-ec26ff2045858945f0e2 | 2021-09-22 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 10V, Negative-QTOF | splash10-00kr-0490000000-f417cafcb8b97a0b794f | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 20V, Negative-QTOF | splash10-014v-2930000000-1bb85cabecbb0f9f11d1 | 2021-09-23 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - 2,2,4-Trimethyl-1,3-pentadienol diisobutyrate 40V, Negative-QTOF | splash10-000i-9300000000-10c1c2804ecaa17eb13c | 2021-09-23 | Wishart Lab | View Spectrum |
|
---|
Disease References | Nonalcoholic fatty liver disease |
---|
- Raman M, Ahmed I, Gillevet PM, Probert CS, Ratcliffe NM, Smith S, Greenwood R, Sikaroodi M, Lam V, Crotty P, Bailey J, Myers RP, Rioux KP: Fecal microbiome and volatile organic compound metabolome in obese humans with nonalcoholic fatty liver disease. Clin Gastroenterol Hepatol. 2013 Jul;11(7):868-75.e1-3. doi: 10.1016/j.cgh.2013.02.015. Epub 2013 Feb 27. [PubMed:23454028 ]
| Perillyl alcohol administration for cancer treatment |
---|
- Silva CL, Passos M, Camara JS: Solid phase microextraction, mass spectrometry and metabolomic approaches for detection of potential urinary cancer biomarkers--a powerful strategy for breast cancer diagnosis. Talanta. 2012 Jan 30;89:360-8. doi: 10.1016/j.talanta.2011.12.041. Epub 2011 Dec 22. [PubMed:22284503 ]
|
|
---|